The 2019 Give to Cure Cancer Year-End Appeal is now underway. It’s your chance to make this year’s campaign the most successful ever.
This past year, we continued to fund several promising cancer research programs. With support from loyal donors like you, excellent…
Specialists warn that single number average survival estimates for advanced stage breast cancer are unhelpful and usually inaccurate. Instead, they advise doctors to provide several case-specific survival estimates to help people plan with realism and hope. Breast cancer is the form of cancer that affects women…
The U.S. Food and Drug Administration recently approved a treatment that combines an immunotherapy drug and chemotherapy for triple negative breast cancer, but not all cases of this aggressive form of breast cancer responded in clinical studies. UNC Lineberger researchers discovered biological…
The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications. Researchers from the Babraham Institute, AstraZeneca and the Cancer Research UK Cambridge Centre have…
Liver cancer is the sixth most common cancer in the world and 4th most common in Asia. It is the second deadliest cancer around the globe, taking more than 746,000 lives in 2012. In Asia, it is also the second deadliest cancer…
Liver cancer death rates have increased by around 50% in the last decade and have tripled since records began, according to the latest calculations by Cancer Research UK. New mortality data shows that there were around 5,700 deaths from liver cancer in 2017 in…
The Asian Fund for Cancer Research and the U.S.-based National Foundation for Cancer Research recently collaborated in an unprecedented manner, with both organizations gathering together. A first-of-its kind partnership, the Joint NFCR and AFCR Scientific Symposium on Cancer Research and Global Collaboration…
Using a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about cancer architecture and could aid the delivery of treatment to the most challenging tumours, new research shows. Magnetic resonance elastography was able to visualise and measure…
The United States Chinese Anti-Cancer Association and AFCR are pleased to invite nominations for the USCACA-AFCR 2019 Scholar Awards.
The Awards will recognize two to three junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research.
Candidacy is open to…
A cancer therapy invented at Rice University has crossed a milestone in clinical trials, a major development in a decades long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation. According to the…